Day One Biopharmaceuticals (DAWN) Stock Surges 66% on Servier's $2.5 Billion Acquisition Deal
Shares of Day One Biopharmaceuticals Inc. (NASDAQ: DAWN) skyrocketed more than 65% on March 6, 2026, after the company announced a definitive agreement to be acquired by French pharmaceutical group Servier for $21.50 per share in cash, valuing the deal at app…